Patent directory · USPTO A61K / A61P
Patents matching “Laboratories Almirall, S.A.”
20 pharma patents match "Laboratories Almirall, S.A." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 20 pharmaceutical patents matching "Laboratories Almirall, S.A." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8420669
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor
granted -
US 8258308
Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
granted -
US 7960383
Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
granted -
US 7906530
1,7-naphthyridine derivatives as p38 MAP kinase inhibitors
granted -
US 7855202
Imidazopyridine derivatives as A2B adenosine receptor antagonists
granted -
US 7790728
Pyrazine derivatives useful as adenosine receptor antagonists
granted -
US 7718670
Quinuclidine amide derivatives
granted -
US 7662814
4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors
granted -
US 7622480
Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
granted -
US 7582676
2-phenylpyran-4-one derivatives as selective COX-2 inhibitors
granted -
US 7560471
Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
granted -
US 7557212
Tricyclic derivatives as LTD4 antagonists
granted -
US 7511038
Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
granted -
US 7504398
Substituted-4-(pyrrolo pyrimidin-6-yl)benzenesulphonamide derivatives
granted -
US 7491722
Pyridazin-3(2H)-one derivatives
granted -
US 7488735
Quinuclidine amide derivatives
granted -
US 7459453
Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
granted -
US 7435742
Quinuclidine derivatives and pharmaceutical compositions containing the same
granted -
US 7358260
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 7253171
Urea derivatives as integrin α4 antagonists
granted